ROGER JEFFS - 03 Apr 2022 Form 4 Insider Report for Liquidia Corp (LQDA)

Role
Chief Executive Officer, Director
Signature
/s/ Roger Jeffs
Issuer symbol
LQDA
Transactions as of
03 Apr 2022
Transactions value $
$0
Form type
4
Filing time
04 Oct 2022, 16:25:10 UTC
Previous filing
20 Apr 2022
Next filing
25 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LQDA Common Stock Options Exercise +47.4K +29.67% 207K 03 Oct 2022 Direct F1, F2
holding LQDA Common Stock 46.6K 03 Apr 2022 See footnote F3
holding LQDA Common Stock 1.54M 03 Apr 2022 See footnote F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LQDA Restricted Stock Unit Options Exercise $0 -47.4K -75% $0.00 15.8K 03 Oct 2022 Common Stock 47.4K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
F2 On January 3, 2022, the Reporting Person was granted 63,230 RSUs with 25% vesting quarterly through the first anniversary of the grant date. Of those RSUs, a total of 47,423 have vested through October 3, 2022.
F3 The securities are held by Roger A. Jeffs Living Trust UAD 2/29/2000 (the "Trust"). The Reporting Person is the trustee of the Trust.
F4 The securities are held by Serendipity BioPharma LLC ("Serendipity"). The Reporting Person is a manager of Serendipity and has sole voting and dispositive power over the Issuer common stock held by Serendipity.